Sanjay Jain (S Jain)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Randomized Controlled Trial

Interstitial Lung Disease

Systemic Sclerosis

Top Venues

Rheumatology international

Rheumatology advances in practice

Autopsy & case reports

QJM : monthly journal of the Association of Physicians

This page only lists publications with an associated author ORCID identifier.

Publications

Mayur Parkhi, Madhumita Premkumar, Amanjit Bal, Ashim Das, Sanjay Jain, Suvradeep Mitra
Acute liver failure caused by lymphocyte-depleted Hodgkin lymphoma in tuberculosis and HIV-infected patient. Autopsy & case reports 14 (2024)
Mayur Parkhi, Madhumita Premkumar, Amanjit Bal, Ashim Das, Sanjay Jain, Suvradeep Mitra
Acute liver failure caused by lymphocyte-depleted Hodgkin lymphoma in tuberculosis and HIV-infected patient. Autopsy & case reports 14 (2024)
Jithin Mathew, Siddharth Jain, Terence Susngi, Godasi Srsnk Naidu, Arghya Chattopadhyay, Aman Sharma, Sanjay Jain, Shefali Khanna Sharma
Predictors of COVID-19 severity and outcomes in Indian patients with rheumatic diseases: a prospective cohort study. Rheumatology advances in practice 7 (1) (2023)
Abhinav Shrivastava, Siddharth Jain, Vikram Damaraju, Godasi Srsnk Naidu, Arghya Chattopadhyay, Manish Rathi, Sandeep Grover, Sanjay Jain, Aman Sharma
Severity and determinants of psychosocial comorbidities in granulomatosis with polyangiitis and their impact on quality of life. Rheumatology international (2023)
Jithin Mathew, Siddharth Jain, Terence Susngi, Godasi Srsnk Naidu, Arghya Chattopadhyay, Aman Sharma, Sanjay Jain, Shefali Khanna Sharma
Predictors of COVID-19 severity and outcomes in Indian patients with rheumatic diseases: a prospective cohort study. Rheumatology advances in practice 7 (1) (2023)
Joydeep Samanta, Godasi Srsnk Naidu, Arghya Chattopadhyay, Amal Basnet, Tarun Narang, Arghya Chattopadhyay, Sunil Dogra, Sanjay Jain, Aman Sharma
Comparison between methotrexate and apremilast in Psoriatic Arthritis-a single blind randomized controlled trial (APREMEPsA study). Rheumatology international (2023)
Arghya Chattopadhyay, Chandra Bhushan Prasad, Sandeep Kumar, Kavya Kriti Kaul, Neha Dung, Godasi Srsnk Naidu, Shefali Khanna Sharma, Aman Sharma, Sanjay Jain
Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study. Rheumatology international (2023)
J Sankar, Jithin Mathew, Sanjay Jain, Arghya Chattopadhyay
Toxic epidermal necrolysis as a manifestation of acute cutaneous lupus erythematosus. Rheumatology (Oxford, England) 61 (9) (2022)
Joydeep Samanta, Godasi Srsnk Naidu, Prateek Deo, Sakshi Mittal, Chandra Bhushan Prasad, Diganta Das, Arghya Chattopadhyay, Shefali Khanna Sharma, Raja Ramachandran, Manish Rathi, Ritambhra Nada, Ranjana Walker Minz, Sanjay Jain, Aman Sharma
Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional study. Rheumatology international 42 (12) (2022)
Joydeep Samanta, Godasi Srsnk Naidu, R Sood, R Nada, Aman Sharma, Sanjay Jain
Calcinosis cutis with amyopathic dermatomyositis. QJM : monthly journal of the Association of Physicians 115 (9) (2022)
Arghya Chattopadhyay, Siddharth Jain, Godasi Srsnk Naidu, Arghya Chattopadhyay, Bharath Chhabria, Nupoor Acharya, Valliappan Muthu, Manphool Singhal, Ajay Savlania, Rajesh Vijayvergiya, Sanjay Jain, Aman Sharma
Clinical presentation and treatment outcomes of arterial involvement in Behçet's disease: a single-centre experience. Rheumatology international (2021)
Nupoor Acharya, Shefali Khanna Sharma, Debashish Mishra, Sahajal Dhooria, Arghya Chattopadhyay, Sanjay Jain
Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease-a randomised controlled trial. Rheumatology international 40 (5) (2020)
Godasi Srsnk Naidu, Shefali Khanna Sharma, M B Adarsh, Arghya Chattopadhyay, Anindita Sinha, Sahajal Dhooria, Sanjay Jain
Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial. Rheumatology international 40 (2) (2019)